Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: Has the case been made?

Regulatory Toxicology and Pharmacology

Volumn 64, Issue 1, 2012, Pages 130-133

  Rhomberg, Lorenz R ^a   Goodman, Julie E ^a  

^a GRADIENT   (United States)

Author keywords

Endocrine disrupting chemicals (EDCs); Low dose effects; Nonmonotonic dose response; Weight of evidence

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR;

ADVERSE OUTCOME; ANIMAL CELL CULTURE; BIOLOGICAL ACTIVITY; CONCENTRATION (PARAMETERS); ENVIRONMENTAL STRESS; HEALTH HAZARD; HUMAN; NONHUMAN; NOTE; POPULATION EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TOXICITY TESTING;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS;

ANIMALIA;

EID: 84864029430     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.06.015     Document Type: Note

References (14)

1. Doerge D.R., Twaddle N.C., Vanlandingham M., Brown R.P., Fisher J.W. Distribution of bisphenol A into tissues of adult, neonatal, and fetal Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 2011, 255:261-270.
2. Elswick B.A., Welsch F., Janszen D.B. Effect of different sampling designs on outcome of endocrine disruptor studies. Reprod. Toxicol. 2000, 14(4):359-367.
3. Elswick B.A., Miller F.J., Welsch F. Comments to the editor concerning the paper entitled " Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals" by C. Gupta. Exp. Biol. Med. (Maywood) 2001, 226(2):74-75.
4. Goodman J.E., Dodge D.G., Bailey L.A. A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. Regul. Toxicol. Pharmacol. 2010, 58:308-322.
5. Goodman J.E., Witorsch R.J., McConnell E.E., Sipes I.G., Slayton T.M., Yu C.J., Franz A.M., Rhomberg L.R. Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit. Rev. Toxicol. 2009, 39:1-75.
6. Kamrin M.A. The 'low dose' hypothesis: validity and implications for human risk. Int. J. Toxicol. 2007, 26(1):13-23.
7. Rhomberg L.R., Bailey L.A., Goodman J.E. Hypothesis-based weight of evidence. A tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action - naphthalene as an example. Crit. Rev. Toxicol. 2010, 40:671-696.
8. Sharpe R.M. Is it time to end concerns over the estrogenic effects of bisphenol A?. Toxicol. Sci. 2010, 114(1):1-4.
9. US EPA Weight of evidence. Evaluating results of EDSP Tier 1 screening to identify the need for Tier 2 testing 2011, Office of Chemical Safety and Pollution Prevention, Endocrine Disruptor Screening Program, Washington, DC.
10. US Food and Drug Administration (US FDA), 2009. Memorandum to M. Hepp (Division of Food Contact Notifications, Regulatory Group 1) Re: Exposure to Bisphenol A (BPA) for Infants, Toddlers and Adults from the Consumption of Infant Formula, Toddler Food and Adult (Canned) Food, FDA-2010-N-0100-0001. Available at: http://www.regulations.gov/#!documentDetail;D=FDA-2010-N-0100-0009.
11. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., Shioda T., Soto A.M., Vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33(3):378-455.
12. vom Saal F.S., Welshons W.V. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ. Res. 2006, 100:50-76.
13. vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Eriksen M., Farabollini F., Guillette L.J., Hauser R., Heindel J.J., Ho S.M., Hunt P.A., Iguchi T., Jobling S., Kanno J., Keri R.A., Knudsen K.E., Laufer H., LeBlanc G.A., Marcus M., McLachlan J.A., Myers J.P., Nadal A., Newbold R.R., Olea N., Prins G.S., Richter C.A., Rubin B.S., Sonnenschein C., Soto A.M., Talsness C.E., Vandenbergh J.G., Vandenberg L.N., Walser-Kuntz D.R., Watson C.S., Welshons W.V., Wetherill Y., Zoeller R.T. Chapel Hill Bisphenol A Expert Panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 2007, 24:131-138.
14. Wolff M.S. Correspondence re: Bisphenol A. Chem. Eng. News 2011, 89(29):4-5.